Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Ping An defends government enforcement actions and handles internal investigations into corporate misconduct on behalf of multinational corporations operating in China and other jurisdictions in Asia, as well as advises on the creation and implementation of corporate compliance programs.

Mr. An has provided regular FCPA and anti-corruption advice to multinationals during mergers and acquisitions, advised companies on compliance risks of proposed transactions, and assisted with revamping and upgrading internal controls and risk mitigation measures.

  • Conducted over 15 internal investigations for several leading multinational research-based pharmaceutical companies operating in China.
  • Conducted multiple investigations for a multinational medical devices company.
  • Advised on compliance issues related to clinical trials and development activities for multiple multinational life sciences companies.
  • Conducted an internal investigation for a global manufacturing company in China.
  • Led an internal investigation for a leading multinational consulting firm in China.
  • Conducted an internal investigation for a global manufacturing company related to allegations of corruption in Southeast Asia.
  • Conducted multiple investigations on behalf of a leading global consumer goods company into allegations of improper payments to officials.
  • Conducted internal investigations on behalf of several leading multinational technology companies.
  • Conducted compliance risk assessments for a multinational pharmaceutical company’s subsidiaries in China, Japan, India, Korea, and Indonesia.
  • Conducted a China anti-bribery and anti-corruption compliance assessment for a multinational pharmaceutical company.
  • Conducted a China compliance program assessment for a U.S. multinational medical devices company.
  • Conducted an anti-bribery and anti-corruption risk assessment in China (as part of the global risk assessment) for a multinational medical devices company.
  • Conducted a risk assessment for a multinational pharmaceutical company’s research and development activities in China.
  • Conducted an assessment of a Japanese life sciences company’s legal and compliance function in Greater China and the rest of the Asia Pacific region.
  • Conducted a compliance risk assessment for a multinational automotive company’s China operations.
  • Conducted a deep dive risk assessment for a multinational food company’s operations in China.
  • Conducted audits of multinational companies’ distributors and licensees in China.
  • Provided ongoing compliance advice to a European medical devices company operating in China.
  • Provided regular anti-corruption advice to a multinational personal care products company.
  • Provided compliance advice and anti-corruption training for US sports leagues operating in China.
  • Advised on the implementation of compliance controls in China for several U.S.-based consumer products companies.
  • First-chaired three jury trials in California courts and three binding arbitrations to verdict.
  • Defended a Chinese client in a U.S. multi-district federal product liability litigation.
  • Enforced judgements by the Hong Kong International Arbitration Centre on behalf of a German company.
  • Defended a leading U.S. food services company in a criminal investigation by Chinese enforcement authorities.
  • Represented the Chinese joint venture partner of a European multinational telecommunications company in an internal investigation for potential FCPA issues.
  • Handled a contract dispute matter for a U.S. consulting firm.